Pharmaceuticals

Reliable excipients and APIs meeting stringent pharmaceutical standards. Supporting safe, effective and compliant drug formulations.

Heap of medical pills in white, blue and other colors. Pills in plastic package. Concept of healthcare and medicine.

485 results found

Sort by

KLUCEL™ JF PHARM

Matrix former designed for controlled release tablets. It can also be used as a binding agent. Benefits:Non-ionic, water solubleAbsorbs moisture from the atmosphere

KLUCEL NUTRA™ D

Binding agent suitable for use in tablets. It is suitable for direct compression.Benefits:Helps to decrease tablet sizeReduces tablet chipping during productionProvides excellent hardness with low friability

KLUCEL™ XTEND HXF PHARM

Matrix former designed for extended-release tablets. It is suitable for direct compression, wet & dry granulation and hot melt extrusion.Benefits:Has high molecular weightSoluble in water and offer high gel strengthProvides consistent release at lower concentrations than HPMCPlasticizer-free hot melt extrusion processability

PHARMASOLVE™ 1

Solubilizer & penetration enhancer for human as well as veterinary parenteral and topical dosage forms. It is used as a solvent for preparation of two-component systems designed for long-acting drug release.Benefits:Helps to improve solubility of drugsEnhances bioavailabilityEXCiPACT GMP certifiedKosher certified, Vegan suitableMeets the requirements of current USP/NF, EP and JPE

PLASDONE™ C-12 1

Solubilizer and crystallization inhibitor suitable for parenteral dosage forms. It can be used as a binder for tablets.Benefits:Has low pyrogen levelEnhances bioavailabilityMeets the requirements of current US, European, Japanese, ChP pharmacopoeias

PLASDONE™ K-25 2 5602

Solubilizer used in solid dispersion pharmaceutical formulations. It acts as a crystallization inhibitor for liquid soft gels. It is also used as a binding agent in tablets.Benefits:Provides hard & non-friable tabletsImproves bioavailability

PLASDONE™ K-29/32 INRT 2 5602

Solubilizer used in solid dispersion pharmaceutical formulations. It is used as a crystallization inhibitor for liquid soft gels. It also acts as a tablet binding-, film coating agent, film former and rheology modifier.Benefits:Improves bioavailabilityProvides hard & non-friable tabletsMeets the requirements of current USP/NF, EP, JP, ChP and EU food purity

PLASDONE™ K-90 INRT 2

Solubilizer used in solid dispersion formulations. It acts as a crystallization inhibitor for liquid soft gels. It is also used as a tablet binding agent, viscosifier, modified release agent and tissue engineering scaffolds.Benefits:Provides hard & non-friable tabletsEnhances bioavailabilityMeets the requirements of current USP/NF, EP, JP, ChP and EU Food purity